Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001072613-26-000301·New Enterprise Associates 15, L.P.
Schedule 13D ownership disclosure
SENTI BIOSCIENCES INC
Common Stock, $0.0001 par value · CUSIP: 81726A209
Event date: 2026-03-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- New Enterprise Associates 15, L.P.Reported CIK 0001629794
Shares: 3,775,615.00 · Class: 12.1%
- NEA Partners 15, L.P.Reported CIK 0001640031
Shares: 3,775,615.00 · Class: 12.1%
- NEA 15 GP, LLCReported CIK 0001640033
Shares: 3,775,615.00 · Class: 12.1%
- Forest BaskettReported CIK 0001277631
Shares: 3,775,615.00 · Class: 12.1%
- Anthony A. Florence, Jr.Reported CIK 0001559827
Shares: 3,775,615.00 · Class: 12.1%
- Mohamad H. MakhzoumiReported CIK 0001630226
Shares: 3,775,615.00 · Class: 12.1%
- Scott D. SandellReported CIK 0001237289
Shares: 3,775,615.00 · Class: 12.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-26-000301
- Form type
- SCHEDULE 13D/A
- Filer
- New Enterprise Associates 15, L.P.
- CIK
- CIK 1629794
- Filed
- Mar 31, 2026
- Reporting period
- Mar 27, 2026
- Description
- Schedule 13D beneficial ownership